Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Rheumatol Int ; 37(6): 1015-1020, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28258473

ABSTRACT

Evaluate the prevalence of sarcopenia on patients with rheumatoid arthritis (RA), the influence of sarcopenia on disease activity and factors associated with sarcopenia. One hundred and twenty-three patients aged over 18 years with RA based on the 1987 ACR/EULAR classification criteria were enrolled. We performed a whole body DXA scan using a dual-energy X-ray absorptiometry (DXA) scanner lunar prodigy to measure fat mass, lean mass, and bone mass in the whole body and body parts. According to the anthropometric equation by Baumgartner et al., sarcopenia was defined as Relative skeletal mass index (RSMI) <5.5 kg/m2 on women and <7.26 kg/m2 on men. Body mass index (BMI) and waist circumference were measured and patients were classified according to World Health Organization. Disease activity was evaluated by: disease activity score 28 ESR (DAS28 ESR), disease activity score 28 CRP (DAS28 CRP), clinical disease activity index (CDAI), simplify disease activity index (SDAI). We measured functional disability by Health assessment questionnaire (HAQ). History and previous medication use including steroids were also checked, and comorbidities were recorded. We analyzed the relation between disease parameters and sarcopenia with the r of Pearson and Spearman. Factors associated and related to sarcopenia were assessed using multiple regression analysis and t independent test. We included 123 patients (107 women). 49 subjects (39.8%) where suffering from sarcopenia, of which 40 women. Most of the sarcopenic patients were between 41 and 50 years old. Sarcopenia on female subjects was not related to parameters of disease activity evaluated by DAS 28, CDAI and SDAI. Most of the sarcopenic patients had normal BMI and abnormal waist circumference. In simple regression analysis sarcopenia was related to BMI, DAS 28 ESR, bone erosion, waist circumference and HAQ. In multiple regression analysis, sarcopenia was positively related to an increase cardiometabolic risk [p = 0.025, OR 0.176, CI (0.038-0.980)], normal BMI [p = 0.004, OR 12.3, CI (2.27-67.6)], over fat BMI [p = 0.004, OR 12.3, CI (2.27-67.6)] and bone erosion [p = 0.012, OR 0.057 CI (0.006-0.532)]. No statistical difference was found according to disease duration and steroids use between sarcopenic and non sarcopenic patients. Sarcopenia is prevalent and related to age, bone erosion, normal/over fat BMI and high cardiometabolic risk according to waist circumference but not with disease activity.


Subject(s)
Arthritis, Rheumatoid/epidemiology , Sarcopenia/epidemiology , Absorptiometry, Photon , Adult , Age Factors , Aged , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/physiopathology , Body Composition , Bone Density , Chi-Square Distribution , Comorbidity , Disability Evaluation , Female , Humans , Linear Models , Male , Middle Aged , Morocco/epidemiology , Obesity/diagnosis , Obesity/epidemiology , Odds Ratio , Prevalence , Prognosis , Prospective Studies , Risk Factors , Sarcopenia/diagnosis , Sarcopenia/physiopathology , Severity of Illness Index , Waist Circumference
2.
Clin Rheumatol ; 32(10): 1487-92, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23743660

ABSTRACT

This study aims to explore patient's concerns when discussing sexual problems caused by chronic low back pain with their healthcare provider. It also aims to identify factors influencing and limiting such communication. A cross-sectional analysis of 100 consenting chronic low back pain sexually active patients was carried out. Patients answered questions on their disease characteristics and sex life. They also mentioned prohibitions of discussing sex with their healthcare provider and their expectations of such discussion. Factors influencing patient's experiences were analyzed. Median of chronic low back pain duration was 36 (24-72) months and back pain intensity using visual analogical scale (0-100 mm) was 50 ± 10.7 mm. Eighty-one percent of our patients complained of sexual problems, 66 % have never discussed the subject with their healthcare provider. Barriers which prevent discussion on sex include the taboo character of the topic, inappropriateness of visit conditions, and patient disinterest in sex. Ninety-three percent of patients expressed the need of sexual problems' management in chronic low back pain consulting. Seventy-four percent expected information and advice from their healthcare provider about recommended intercourse positions so as to avoid pain. Thirty-three percent of patients wanted their partner to be involved in the discussion and 81 % preferred talking with a healthcare provider of the same gender. Ability to communicate on the topic was associated with the decrease of patient sexual satisfaction and limited by patient illiteracy. Our study evidences that sex discussion between patient and healthcare provider is restricted by several barriers and that patients expect more involvement from their healthcare provider on the subject. Illiteracy and level of sexual satisfaction seem to be the strongest factors influencing this communication.


Subject(s)
Chronic Pain/physiopathology , Low Back Pain/physiopathology , Sexual Dysfunction, Physiological/diagnosis , Adult , Chronic Pain/psychology , Communication , Cross-Sectional Studies , Female , Humans , Libido , Low Back Pain/psychology , Male , Middle Aged , Multivariate Analysis , Professional-Patient Relations , Sexual Behavior , Sexual Dysfunction, Physiological/psychology , Surveys and Questionnaires
3.
Rheumatol Int ; 33(5): 1277-81, 2013 May.
Article in English | MEDLINE | ID: mdl-23124732

ABSTRACT

The purpose of this study was to assess prevalence and severity of insomnia in participants diagnosed with chronic low back pain (CLBP) and to identify factors associated with this insomnia. One hundred CLBP consenting participants were recruited. Sociodemographic, CLBP features and sleep characteristics were collected. Patients answered validated measures of insomnia severity and fatigue. Statistical analysis examined the relationship between insomnia, sociodemographic characteristics of patients and CLBP parameters. Seventy-eight percent of patients suffered from insomnia. Insomnia due to back pain was reported in 64 % of cases. Insomnia was early, middle and late in, respectively, 39, 60 and 41 % of patients. Insomnia was sub-threshold, moderate and severe in, respectively, 34, 42 and 2 % of patients. ISI Global score was at 18.07 ± 7.3. ISI correlated significantly with pain intensity (r = 0.587; p < 0.0001), fatigue level (r = 0.495; p < 0.0001) and body mass index (r = -0.209; p = 0.03). Multiple linear regression models have revealed that pain intensity (ß = 1.984; 95 % CI (1.517-2.451); p < 0.0001) and fatigue (ß = 0.284; 95 % CI (0.192-0.377); p < 0.0001) were the strongest determinants for predicting insomnia in CLBP patients. Our study suggests that the prevalence of insomnia is important in CLBP patients, occurring especially at the middle of sleep. Insomnia was essentially sub-threshold or moderate. Back pain and fatigue experienced by patients were the strongest factors associated with this insomnia.


Subject(s)
Chronic Pain/epidemiology , Low Back Pain/epidemiology , Sleep Initiation and Maintenance Disorders/epidemiology , Adult , Chronic Pain/diagnosis , Fatigue/epidemiology , Female , Humans , Linear Models , Low Back Pain/diagnosis , Male , Middle Aged , Morocco/epidemiology , Multivariate Analysis , Pain Measurement , Prevalence , Risk Factors , Severity of Illness Index , Sleep , Sleep Initiation and Maintenance Disorders/diagnosis , Sleep Initiation and Maintenance Disorders/physiopathology , Surveys and Questionnaires
4.
J Clin Densitom ; 10(2): 153-6, 2007.
Article in English | MEDLINE | ID: mdl-17485031

ABSTRACT

Diagnostic discordance for osteoporosis is the observation that the T-score of a patient varies between skeletal sites, falling into 2 different diagnostic categories identified by the World Health Organization classification system. Densitometrists and clinicians should expect that at least 4 of every 10 patients tested by dual-energy X-ray absorptiometry (DXA) to demonstrate T-score discordance between spine and total hip measurement sites. T-score discordance can occur for a variety of reasons related to physiologic and pathologic patient factors and the performance or analysis of DXA itself.


Subject(s)
Absorptiometry, Photon/methods , Hip/diagnostic imaging , Osteoporosis/diagnostic imaging , Spine/diagnostic imaging , Bone Density , Diagnosis, Differential , Diagnostic Errors , Humans , Osteoporosis/epidemiology , Osteoporosis/metabolism , Risk Factors , Severity of Illness Index
5.
Clin Rheumatol ; 26(8): 1386-8, 2007 Aug.
Article in English | MEDLINE | ID: mdl-16944069

ABSTRACT

The vertebral hydatidosis is uncommon. It causes problems in diagnosis and in management. A case of an extensive vertebral hydatidosis with few symptoms is reported. A 21-year-old man has consulted for recurrent lumbosciatica that has been evolving for 1 year. Clinical exam was normal. Plain radiographic films disclosed a lytic lesion throughout the bodies of L4 and L5 and calcifications thrown on the liver area. The computed tomography (CT) and the magnetic resonance (MR) images revealed multicystic bony lesions involving the lumbar spine with extension into the spinal canal. Abdominal ultrasound showed also cyst lesions in the right kidney and in the liver. The diagnosis of vertebral and abdominal (liver and kidney) hydatidosis was retained. Four sets of 4-week albendazole cures were given with a 2-week interval in between. Our case of extended vertebral hydatidosis with few symptoms confirms the clinical latency and diagnosis difficulties usually encountered in this disease. This often leads to a late diagnosis of the stage of spinal cord compression. Radiological diagnosis and determination of extension of the hydatid cyst are usually provided by CT and MRI. Vertebral hydatidosis should be evoked in lumbosciatica especially in endemic regions.


Subject(s)
Echinococcosis/complications , Echinococcosis/drug therapy , Low Back Pain/etiology , Sciatica/etiology , Adult , Albendazole/therapeutic use , Antiprotozoal Agents/therapeutic use , Echinococcosis/diagnosis , Humans , Magnetic Resonance Imaging , Male , Sacrum/parasitology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...